Τόμος 22 (2004) – Τεύχος 3 – Άρθρο 6 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση – Volume 22 (2004) – Issue 2 – Article 6 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition

Ιωάννης Φλώρος*, Μαρία Μυρωνίδου-Τζουβελέκη**, Ανδρέας Πάγκαλης*, Κωνσταντίνος Καλούσης**, Βασίλης Κόκκας**

* Κλινική Εντατικής Θεραπείας του Πανεπιστημίου Αθηνών, Νοσοκομείο Ευαγγελισμός, Αθήνα, Ελλάς ** Εργαστήριο Φαρμακολογίας, Ιατρική Σχολή, Αριστοτέλειο Πανεπιστήμιο, Θεσσαλονίκη, Ελλάς

I. Floros*, M. Mironidou-Tzouveleki**, A. Pangalis*, K. Kalousis**, B. Kokkas**

* Intensive Care Clinic, Evangelismos Hospital, University of Athens, Athens, Greece ** Department of Pharmacology, Medical School, Aristotle University, Thessaloniki, Greece

2. Baue Α.Ε.: Multiple progressive, or sequential sys­tems failure. Α syndrome of the 1970s. Arch. Surg. 110: 779-781 (1975)

3. Angus D.C., Linde-Zwirble W.T., Lidicker J., Cler­mont G., Carcillo J., Pinsky M.R.: Epidemiology of severe sepsis in the United States: Analysis of inci­dence, outcome, and associated costs of care. Crit. Care Med. 29: 1303-1310 (2001)

4. Brun-Buisson C.: Epidemiology of MOF. Intens. Care Med. 25: S64-74 (2000)

5. Bone R.C.: Sir Isaac Newton, sepsis, SIRS and CARS. Crit. Care Med. 24: 1125-1128 (1996)

6. Hotchkiss R.S., Swanson Ρ.Ε., Freemann B.D., Tinsley K.W., Cobb J.P., Matuschaak G.M., Buchman T.G., Karl Ι.Ε.: Apoptotic cell death in patients with sepsis, shock and multiple organ dysfunction. Crit. Care Med. 27: 1230-1251 (1999)

7. Ulevitch R.J.: New therapeutic targets revealed through investigations of innate immunity. Crit. Care Med. 29: 8-12 (2001)

8. Wilhelm W., Grundmann U., Rensing H., Werth Μ., Langemeyer J., Stracke C., Dhingra D., Bauer Μ.: Monocyte deactivation in severe human sepsis or fol­lowing cardiopulmonary bypass. Shock 17: 354-360 (2002)

9. Libermann T.A., Baltimore D.: Activation of inter­leukin-6 gene expression through the NF-kappa Β transcription factor. Mol. Cell Βiοl. 10: 2327-2334 (990)

10. Βöhrer Η., Qiu F., Zimmermann Τ., Zhang Υ., Jllmer Τ., Mannel D., Bottiger B.W., Stem D.M., Wald­herr R., Saeger H.D., Ziegler R., Bierhaus Α., Martin E., Nawroth Ρ.Ρ.: Role of Nf kappa B in the mortality of sepsis. J. Clin. Invest. 100: 972-985 (1997)

11. Bauer Μ., Rensing Η., Ziegenfuss Τ.: Anesthesie und perioperative Immunfunktion. Anesthesist 47: 538-556 (1998)

12. Grundmann U., Rensing H., Adams Η.Α., Falk S., Wendler Ο., Ebinger Ν., Bauer Μ.: Endotoxin desensi­tization of human mononuclear cells after cardiopul­monary bypass: role of humoral factors. Anesthesiol­ogy 93: 359-369 (2000)

13. Rangel F.M., Pittet D., Costigan Μ., Hwang Τ., Davis C.S., Wenzel R.P.: The natural history of the systemic inflammatory response syndrome (SIRS). Α prospective study. JAMA 273: 117-123 (1995)

14. Roumen R.M., Hendriks Τ., van der Ven Jongekrijg J., Νieuwenhuijzen G.A., Sauerwein R.W., van der Meer J.W., Goris R.J.: Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ fail­ure. Ann. Surg. 218: 769-776 (1993)

15. Waage Α., Halstensen Α., Espevik Τ.: Association between tumor necrosis factor in serum and fatal out­come in patients with meningococcal disease. Lancet 1: 355-357 (1987)

16. Echtenacher Β., Falk W., Mannel D.N., Κrammer Ρ.Η.: Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental perito­nitis. J. Immunol. 145: 3762-3766 (1990)

17. Rensing Η., Bauer I., Datene V., Patau C., Pannen Β.Η., Bauer Μ.: Differential expression pattern of heme oxygenase-l/heat shock protein 32 and nitric oxide synthase-II and their impact οn liver injury in a rat model of hemorrhage and resuscitation. Crit. Care Med. 27: 2766-2775 (1999)

18. Rensing Η., Jaeschke Η., Bauer Ι., Patau C., Datene Y., Pannen Β.Η., Bauer Μ.: Differential activa­tion pattern of redox-sensitive transcription factors and stress-inducible dilator systems heme oxygenase-l and inducible nitric oxide synthase in hemorrhagic and endotoxic shock. Crit. Care Med. 29: 1962-1971 (2001)

19. Μάνδαλος Α., Μαυρακάνας Θ., Ζάνος Σ., Μήλτσιος Κ., Μπολομύτης Σ., Μυρωνίδου-Τζουβελέκη Μ.: Νεώτερα δεδομένα στην έρευνα για το Μονοξείδιο του αζώτου (ΝΟ). Από τη φυσιολογία στην κλινική πράξη. Επι-θεώρ. Κλιν. Φαρμακολ. Φαρμακοκινητ. 19: 5-24 (2001)

20. Fink Μ.Ρ.: Cytopathic hypoxia. Mitochondrial dys­function as mechanism contributing to organ dysfunc­tion in sepsis. Crit. Care Clin. 17: 219-237 (2001)

21. Vallance Ρ., Moncada S.: Role of endogenous nitric oxide in septic shock. N. Ηoriz. 1: 77-86 (1993)

22. MacNaul Κ.L., Hutchinson Ν.Ι.: Differential expres­sion of iNOS and cNOS mRNA in human vascular smooth muscle cells and endothelial cells under nor­mal and inflammatory conditions. Biochem. Biophys. Res. Commun. 196: 1330-1334 (1993)

23. Kilboum R.G., Gross S.S., Jubran Α., Adams J., Griffith O.W., Levi R., Lodato R.F.: NG-methyl-L-ar­ginine inhibits tumor necrosis factor-induced hypoten­sion: implications for the involvement of nitric oxide. Proc. Natl. Acad. Sci. USΑ 87: 3629-3632 (1990)

24. Kilboum R.G., Jubran Α., Gross S.S., Griffith O.W., Levi R., Adams J., Lodato R.F.: Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem. Biophys. Res. Com. 172: 1132-1138 (1990)

25. Grover R., Zaccardelli D., Colice G., Guntupalli Κ., Watson D., Vincent J.L.: An open-label dose escalation study of the nitric oxide synthase inhibitor, N(G)-methyl-L-arginine hydrochloride (546C88), in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group. Crit. Care Med. 27: 913-922 (1999)

26. Booke Μ., Hinder F., McGuire R., Traber L.D., Traber D.L.: Selective inhibition of inducible nitric oxide synthase: effects οn hemodynamics and regional blood flow in healthy and septic sheep. Crit. Care Med. 27: 162-167 (1999)

27. Heyland D.K., Cook D.J., King D., Kemerman Ρ., Brun B.C.: Maximizing oxygen delivery in critically ill patients: a methodologic appraisal of the evidence. Crit. Care Med. 24: 517-524 (1996)

28. Hoffmann J.N., Werdan Κ., Hartl W.H., Jochum Μ., Feist Ε., Inthom D.: Hemofiltrate from patients with severe sepsis and depressed left ventricular contractil­ity contains cardiotoxic compounds. Shock 12: 174-180 (1999)

29. Bauer M., Marzi Ι., Ziegenfuss Τ., Riegel W.: Pro­phylactic hemofiltration in severely traumatized pa­tients: effects on post-traumatic organ dysfunction syndrome. Intens. Care Med. 27: 376-383 (2001)

30. Sakr Y., Dubois M.J., De Backer D., Creteur J., Vincent J.L.: Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit. Care Med. 32: 1825-1831 (2004)

31. Berg R.D.: Promotion of the translocation of enteric bacteria from the gastrointestinal tracts of mice by oral treatment with penicillin, clindamycin, or metronida­zole. Infect. Immun. 33: 854-861 (1981)

32. Berg R.D.: Bacterial translocation from the gastro­intestinal tract. Adv. Exp. Med. Βiοl. 473: 11-30 (1999)

33. Waaij D.Y., Berghuis-de V.J., Lekkerkerk L.: Colo­nisation resistance of the digestive tract in conven­tional and antibiotic-treated mice. J. Hyg. Lond. 69: 405-411 (1971)

34. Deitch Ε.Α.: The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multiple organ failure. Arch. Surg. 125: 403-404 (1990)

35. O’Boyle C.J., MacFie J., Mitchell C.J., Johnstone D., Sagar Ρ.Μ., Sedman P.C.: Microbiology of bacterial translocation in humans. Gut 42: 29-35 (1999)

36. Marshall J.C., Christou Ν.Υ., Meakins J.L.: The gastrointestinal tract. The undrained abscess of multi­ple organ failure. Ann. Surg. 218: 111-119 (1993)

37. Majno G., Joris I.: Apoptosis, oncosis and necrosis. An overview of cell death. Am. J. Pathol. 146: 3-15 (1995)

38. Lemasters J.J., Nieminen Α.Ι., Qian Τ., Trost L.C, Elmore S.P., Nishimura Υ., Crowe R.A., Cascio W.E., Bradham C.A., Brenner D.A., Herman Β.: The mito­chondrial permeability transition in cell death: a com­mon mechanism in necrosis, apoptosis and autophagy. Biochim. Biophys. Acta 1366: 177-196 (1998)

39. Paxian M., Rensing H., Rickauer A., Schonhofen S., Schmeck J., Pannen B.H., Bauer I., Bauer M.: Kupffer cells and neutrophils as paracrine regulators of the heme oxygenase-1 gene in hepatocytes after hemorrhagic shock. Shock 15: 438-445 (2001)

40. Pepe Ρ.Ε., Hudson L.D., Carrico C.J.: Early appli­cation of positive and – expiratory pressure in patients at risk for the adult respiratory – distress syndrome. Ν. Engl. J. Med. 311: 281-286 (1984)

41. Amato Μ.Β., Barbas C.S., Medeiros D.M., Schet­tino G.D., Lorenzi F.G., Kairalla R.A., Deheinzelin D., Morais C., Femandes E.D., Takagaki Τ.Υ., et al.: Beneficial effects of the “open lung approach” with low distending pressures in acute respiratory distress syn­drome. Α prospective randomized study on mechanical ventilation. Am. J. Respir. Crit. Care Med. 152: 1835-1846 (1995)

42. The Acute Respiratory Distress Syndrome Net­work: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. Ν. Engl. J. Med. 342: 1301-1308 (2000)

43. Kacmarek R.M.: Ventilator-associated lung injury. Intern. Anesthesiol. Clin. 37: 47-64 (1999)

44. Tremblay Ι.Ν., Slutsky A.: Ventilator induced injury: from barotrauma to biotrauma. Proc. Ass. Am. Physi­cians 110: 482-488 (1998)

45. Dreyfuss D., Basset G., Soler Ρ., Saumon G.: In­termittent positive-pressure hyperventilation with high inflation pressures produces pulmonary microvascular injury in rats. Am. Rev. Respir. Dis. 132: 880-884 (1985)

46. Kolobow Τ., Moretti Μ.Ρ., Fumagalli R., Mascheroni D., Prato Ρ., Chen V., Joris Μ.: Severe impairment in lung function induced by high peak air­way pressure during mechanical ventilation. An ex­perimental study. Am. Rev. Respir. Dis. 135: 312-315 (1987)

47. Ranieri Υ.Μ., Suter Ρ.Μ., Tortorella C., De T.R., Dayer J.M., Βrienza Α., Bruno F., Slutsky A.S.: Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA 282: 54-61 (1999)

48. Stewart Τ.Ε., Meade Μ.O., Cook D.J., Granton J.T., Hodder R.V., Lapinsky S.E., Mazer C.D., McLean R.F., Rogovein T.S., Schouten B.D., Τodd T.R., Slut­sky Α.: Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome. Pressure and Volume-Limited Ven­tilation Strategy Group. Ν. Engl. J. Med. 338: 355-361 (1998)

49. Brochard L., Roudot-Thoraval F., Roupie E., Del­claux C., Chastre J., Fernandez-Mondejar E., et al.: Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syn­drome. The Multicenter Trail Group on Tidal Volume reduction in ARDS. Am. J. Respir. Crit. Care Med. 158: 1831-1838 (1998)

50. Gentilello Ι.Μ., Anardi D., Mock C., Areola R.C., Maier R.V.: Permissive hypercapnia in trauma patients. J. Trauma 39: 846-852 (1995)

51. McIntyre-RC J., Haenel J.B., Moore F.A., Read R.R., Burch J.M., Moore Ε.Ε.: Cardiopulmonary effects of permissive hypercapnia in the management of adult respiratory distress syndrome. J. Trauma 37: 433-438 (1994)

52. Abel S.J., Finney S.J., Brett S.J., Morgan C.J., Evans T.W.: Reduced mortality in association with the acute respiratory distress syndrome (ARDS). Thorax 53: 292-294 (1998)

53. Bein Τ., Reber Α., Metz C., Jauch K.W., Heden­stiema G.: Acute effects of continuous rotational ther­apy on ventilation perfusion inequality in lung injury. Intens. Care Med. 24: 132-137 (1998)

54. Staudinger Τ., Kofler J., Mullner Μ., Locker G.J., Laczika Κ., Κnapp S., Losert Η., Frass Μ.: Comparison of prone positioning and continuous rotation of patients with adult respiratory distress syndrome: results of a pilot study. Crit. Care Med. 29: 51-56 (2001)

55. Rossaint R., Falke K.J., Lopez F., Slama Κ., Pison U., Zapol W.M.: Inhaled nitric oxide for the adult respi­ratory distress syndrome. Ν. Engl. J. Med. 328: 399-405 (1993)

56. Dellinger R.P., Zimmerman J.L., Taylor R.W., Straube R.C., Hauser D.L., Criner G.J., Davis Κ., Hyers T.Μ., Papadakos Ρ.: Effects of inhaled nitric oxide in patients with acute respiratory distress syn­drome: results of a randomized phase ΙΙ trial. Inhaled Nitric Oxide in ARDS Study Group. Crit. Care Med. 26: 15-23 (1998)

57. Lundin S., Mang Η., Smithies Μ., Stenqvist Ο., Frostell C.: Inhalation of nitric oxide in acute lung in­jury: results of a European multicentre study. The European Study Group of Inhaled Nitric Oxide. Intens. Care Med. 25: 911-919 (1999)

58. Michael J.R., Barton R.G., Saffle J.R., Mone Μ., Markewitz Β.Α., Hillier Κ., Elstad M.R., Campbell E.J., Troyer Β.Ε., Whatley R.E., Liou T.G., Samuelson W.M., Carveth H.J., Hinson D.M., Morris S.E., Davis B.L., Day R.W.: Inhaled nitric oxide versus conven­tional therapy: effect οn oxygenation in ARDS. Am. J. Respir. Crit. Care Med. 157: 1372-1380 (1998)

59. Troncy Ε., Collet J.P., Shapiro S., Guimond J.G., Blair L., Ducruet T., Francoeur Μ., Charbonneau M., Blaise G.: Inhaled nitric oxide in acute respiratory dis­tress syndrome: a pilot randomized controlled study. Am. J. Respir. Crit. Care Med. 157: 1483-1488 (1998)

60. McIntyre R.C., Pulido E.J., Bensard D.D., Shames B.D., Abraham Ε.: Thirty years of clinical trials in acute respiratory distress syndrome. Crit. Care Med. 28: 3314-3331 (2000)

61. Grocott M.R., Shah Α.Μ.: Cardiac dysfunction in sepsis: new theories and clinical implications. Intens. Care Med 24: 286-295 (1998)

62. Hayes Μ.Α., Yau Ε.Η., Timmins A.C., Hinds C.J., Watson D.: Response of critically ill patients to treat­ment aimed at achieving supranormal oxygen delivery and consumption. Relationship to outcome. Chest 103: 886-895 (1993)

63. Gattinoni L., Brazzi L., Pelosi Ρ., Latini R., Tognoni G., Pesenti Α., Fumagalli R.: Α trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. Ν. Engl. J. Med. 333: 1025-1032 (1995)

64. Silverman H.J., Tuma Ρ.: Gastric tonometry in patients with sepsis. Effects of dobutamine infusions and packed red blood cell transfusions. Chest 102: 184-188 (1998)

65. Marik Ρ.Ε., Sibbald W.J.: Effect of stored blood transfusion οn oxygen delivery in patients with sepsis. JAMA 269: 3024-3029 (1993)

66. Babineau T.J., Dzik W.H., Borlase B.C., Baxter J.K., Bistrian BR, Benotti ΡΝ. Reevaluation of current transfusion practices in patients in surgical intensive care units. Am. J. Surg. 164: 22-25 (1992)

67. Conrad S.A., Dietrich Κ.Α., Hebert C.A., Romero M.D.: Effect of red cell transfusion on oxygen con­sumption following fluid resuscitation in septic shock. Circ. Shock 31: 419-429 (1990)

68. Dietrich Κ.Α., Conrad S.A., Hebert C.A., Levy G.L., Romero M.D.: Cardiovascular and metabolic response to red blood cell transfusion in critically ill volume-re­suscitated non surgical patients. Crit. Care Med. 18: 940-944 (1990)

69. Fenwick J.C., Dodek Ρ.Μ., Ronco J.J., Phang Ρ.Τ., Wiggs Ρ., Russell J.A.: Increased concentrations of plasma lactate predict pathologic dependence of oxy­gen consumption in patients with sepsis. J. Crit. Care 5: 81-86 (1990)

70. Gilbert Ε.Μ., Haupt Μ.Τ., Mandanas R.Y., Huarin-ga A.J., Carlson R.W.: The effect of flyid loading, blood transfusion and catacholamine infusion on oxygen delivery and consumption in patients with sepsis. Am. Rev. Respir. Dis. 134: 873-878 (1986)

71. Gramm J., Smith S., Gamelli R.L., Dries D.J.: Ef­fect of transfusion on oxygen transport in critically ill patients. Shock 5: 190-193 (1996)

72. Kahn R.C., Zaroulis C., Goetz W., Howland W.S.: Hemodynamic oxygen transport and 2,3­diphospho-glycerate changes after transfusion of pa­tients in acute respiratory failure. Intens. Care Med. 12: 22-25 (1986)

73. Lorente J.A., Landin Ι., De Pablo R., Renes Ε., Rodriguez D.R., Liste D.: Effects of blood transfusion on oxygen transport variables in severe sepsis. Crit. Care Med. 21: 1312-1318 (1993)

74. Lucking S.E., Williams T.M., Chaten F.C., Metz R.I., Mickell J.J.: Dependence of oxygen consumption on oxygen delivery in children with hyperdynamic sep­tic shock and low oxygen eχtraction. Crit. Care Med. 18: 1316-1319 (1990)

75. Marik P.E., Mohedin Μ.: The contrasting effects of dopamine and norepinephrine on systemic and splachnic oxygen utilization in hyperdynamic sepsis. JAMA 272: 1354-1357 (1994)

76. Mink R.B., Pollack Μ.Μ.: Effect of blood transfusion on oxygen consumption in pediatric septic shock. Crit. Care Med. 18: 1087-1091 (1990)

77. Ronco J.J., Montaner J.S., Fenwick J.C., Ruedy J., Russell J.A.: Pathologic dependence of oxygen con­sumption on oxygen delivery in acute respiratory fail­ure secondary to AIDS related Pneumocystis carinii pneumonia. Chest 98: 1463-1466 (1990)

78. Ronco J.J., Phang P.T., Walley K.R., Wiggs Β., Fenwick J.C., Russell J.A.: Oxygen consumption is independent of changes in oxygen delivery in severe adult respiratory distress syndrome. Am. Rev. Respir. Dis. 143: 1267-1273 (1991)

79. Shah D.M., Gottlieb M.E., Rahm R.L., Stratton Η.Η., Barie P.S., Paloski W.H., Newell J.C.: Failure of red blood cell transfusion to increase oxygen transport or miχed venous ΡΟ₂ in injured patients. J. Trauma 22: 741-746 (1982)

80. Steffes C.P., Bender J.S., Levison Μ.Α.: Blood transfusion and oxygen consumption in surgical sep­sis. Crit. Care Med. 19: 512-517 (1991)

81. Hebert P.C., Wells G., Blajchman Μ.Α., Marshall J., Martin C., Pagliarello G., Tweeddale Μ., Schweitzer Ι., Yetisir Ε.: Α multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investiga­tors, Canadian Critical Care Trials Group. Ν. Engl. J. Med. 340: 409-417 (1991)

82. Corwin Η.Ι., Gettinger Α., Rodriguez R.M., Pearl R.G., GubIer Κ.D., Enny C., Colton Τ., Corwin M.J.: Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, pla­cebo-controlled trial. Crit. Care Med. 27: 2346-2350 (1999)

83. Gabriel Α., Kozek S., Chiari Α., FitzgeraId R., Grabner C., Geissler Κ., Zimpfer Μ., Stockenhuber F., Bircher N.G.: High-dose recombinant human erythro­poietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome. J. Trauma 44: 361-367 (1998)

84. Bunn F., Lefebvre C., Li W.P., Li L., Roberts Ι., Schierhout G.: Human albumin solution for resuscita­tion and volume expansion in critically ill patients. The Albumin Reviewers. Cochrane Database Syst. Rev. 2: CD001208 (2000)

85. Bunn F., Alderson Ρ., Hawkins V.: Colloid solutions for fluid resuscitation. Cochrane Database Syst. Rev. 2: CD001319 (2000)

86. Schortgen F., Lacherade J.C., Bruneel F., Catta­neo Ι., Hemery F., Lemaire F., Brochard L.: Effects of hydroxyethylstarch and gelatin οn renal function in severe sepsis: a multicentre randomized study. Lancet 357: 911-916 (2001)

87. Hollenberg S.M., Ahrens T.S., Annane D., Astiz M.E., Chalfin D.B., Dasta J.F., et al. : Practice pa­rameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit. Care Med. 32: 1928-1948 (2004)

88. O’Leary M.J., Bihari D.J.: Preventing renal failure in the critically ill. There are no magic bullets – just high quality intensive care. BMJ 16: 1437-1439 (2001)

89. Ortolani Ο., Conti Α., De G.A., Moraldi Ε., Cantini Q., Novelli G.: The effect of glutathione and N-acetyl­cysteine οn lipoperoxidative damage in patients with early septic shock. Am. J. Respir. Crit. Care Med. 161: 1907-1911 (2000)

90. Horn Ν., Unger J., Rossaint R.: Extrakorporale Leberunterstützungsverfahren in der Therapie des akuten Leberversagens. Eine Standortbestimmung. Anaesthesist 48: 387-394 (1999)

91. Liberati Α., D’ Amicο R., Pifferi S., Leonetti C., Τorri V., Brazzi L., Tinazzi Α.: Antibiotics for preventing res­piratory tract infections in adults receiving intensive care. Cochrane Database Syst. Rev. 2: CD000022 (2000)

92. Liberati Α., D’ Amicο R., Pifferi S., Telaro Ε.: Anti­biotic prophylaxis in intensive care units: metaanalyses versus clinical practice. Intens. Care Med. (Suppl 1) 26: S38-44 (2000)

93. Kudsk Κ.A., Croce Μ.Α., Fabian T.C., Minard G., Tolley E.A., Poret H.A., Kuhl M.R., Brown R.O.: Enteral versus parenteral feeding. Effects on septic morbidity after blunt and penetrating abdominal trauma. Ann. Surg 215: 503-511 (1992)

94. Moore F.A., Moore Ε.Ε.: The benefιts of enteric feeding. Adv. Surg. 30: 141-154 (1996)

95. Koretz R.L.: Nutritional supplementation in the ICU. How critical is nutrition for the critically ill? Am. J. Res­pir. Crit. Care Med. 151: 570-573 (1995)

96. Heys S.D., Walker L.G., Smith Ι., Eremin Ο.: En­tera1 nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analy­sis of randomized controlled clinical trials. Ann. Surg. 229: 467-477 (1999)

97. Hoffmann J.N., Werdan Κ., Hartl W.H., Jochum Μ., Faist Ε., Inthom D.: Hemofiltrate from patients with severe sepsis and depressed left ventricular contractil­ity contains cardiotoxic compounds. Shock 12: 174-180 (1999)

98. Bernieh B., Al Hakim M., Boobes Y., Siemkovics E., El Jack H.: Outcome and predictive factors of acute renal failure in the intensive care unit. Transplant. Proc. 36: 1784-1787 (2004)

99. Pinsky M.R.: Dysregulation of the immune re­sponse in severe sepsis. Am. J. Med. Sci. 328(4): 220-229 (2004)

100. Volk H.D., Reinke Ρ., Κrausch D., Zuckermann Η., Asadullah Κ., Muller Ι.Μ., Döcke W.D., Κοx W.J.: Monocyte deactivation – rationale for a new therapeutic strategy in sepsis. Intens. Care Med. 22 (Suppl 4): 474-481 (1996)

101. Faist Ε., Wichmann Μ., Kim D.: Immunosuppres­sion and immunomodulation in surgical patients. Curr. Opin. Anaesthesiol. 3: 293-298 (1997)

102. Alejandria Μ.Μ., Lansang Μ.Α., Dans L.F., Man­taring J.B.: Intravenous immunoglobulin for treating sepsis and septic shock (Cochrane Review). Cochrane Database Syst. Rev. 2: CD001090 (2001)

103. Werdan Κ.: Pathophysiology of septic shock and multiple organ dysfunction syndrome and various therapeutic approaches with special emphasis οn im­munoglobulins. Ther. Apher. 5: 115-122 (2001)

104. Lefering R., Neugebauer Ε.Α.: Steroid contro­versy in sepsis and septic shock: a metaanalysis. Crit. Care Med. 23: 1294-1303 (1995)

105. Bouachour G., Tirot Ρ., Gouello J.P., Mathieu E., Vincent J.F., Alquier Ρ.: Adrenocortical function during septic shock. Intens. Care Med. 21: 57-62 (1995)

106. Marik P.E., Zaloga G.P.: Adrenal insufficiency during septic shock. Crit. Care Med. 31: 141-145 (2003)

107. Bollaert Ρ.Ε., Charpentier C., Levy Β., Debouverie Μ., Audibert G., Larcan Α.: Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit. Care Med. 26: 645-650 (1998)

108. Briegel J., Forst Η., Haller Μ., Schelling G., Kilger Ε., Kuprat G., Hemmer B., Hummel Τ., Lenhart Α., Heyduck Μ., Stoll C., Peter Κ.: Stress doses of hydro­cortisone reverse hyperdynamic septic shock: a pro­spective, randomized, double blind, single-center study. Crit. Care Med. 27: 723-732 (1999)

109. Annane D., Bellissant E., Bollaert P.E., Briegel J., Keh D., Kupfer Y.: Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analy­sis. BMJ 329(7464): 464-480 (2004)

110. Gando S., Nanzaki S., Kemmotsu Ο.: Dissemi­nated intravascular coagulation and sustained sys­temic inflammatory response syndrome predict organ dysfunctions after trauma: application of clinical deci­sion analysis. Ann. Surg. 229: 121-127 (1999)

111. Taylor-F.B.,Jr, Steams Κ.D., Kurosawa S., Ferrell G., Chang A.C., Laszik Ζ., Kosanke S., Peer G., Es­mon C.T.: The endothelial cell protein C receptor aids in host defence against Escherichia coli sepsis. Blood 95: 1680-1686 (2000)

112. Baudo F., Caimi Τ.Μ., de Cataldo F., Ravizza Α., Arlati S., Casella G., Carugo D., Palareti G., Legnani C., Ridolfi L., Rossi R., D Άngelο Α., Crippa L., Giudici D., Gallioli G., Wolfler Α., Calori G.: Antithrombin III (ΑΤ III) re­placement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study. Intens. Care Med. 24: 336-342 (1998)

113. Eisele Β., Lamy M., Thijs L.G., Keinecke Η.Ο., Schuster Η.Ρ., Matthias F.R., Fourrier F., Heinrichs H., Delvos U.: Antithrombin III in patients with severe sep­sis. Α randomized, placebo controlled, double-blind multicenter trial plus a meta-analysis on all random­ized, placebo-controlled, double-blind trials with anti­thrombin III in severe sepsis. Intens. Care Med. 24: 663-672 (1998)

114. Fourrier F., Chopin C., Huart J.J., Runge I., Caron C., Goudemand J.: Double-blind, placebo controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation. Chest 104: 882-888 (1993)

115. Abraham Ε.: Tissue factor inhibition and clinical trial results of tissue factor pathway inhibitor in sepsis. Crit. Care Med. 28: S31-S33 (2000)

116. Bernard G.R., Vincent J.L., Laterre P.F., LaRosa S.P., Dhainaut J.F., Lopez-Rodriguez Α., Steingrub J.S., Garber G.E., Helterbrand J.D., Εly E.W., Fisher C.-J.J.: Efficacy and safety of recombinant human activated protein C for severe sepsis. Ν. Engl. J. Med. 344: 699-709 (2001)

117. Singer M., De Santis V., Vitale D., Jeffcoate W.: Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflam­mation. Lancet 364(9433): 545-548 (2004)